VERVE THERAPEUTICS INC

CUSIP: 92539P101 Class: Common Stock

Bank of New York Mellon Corp's Holding History (CIK: 0001390777)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 220,788 Value ($000) $2,479 Avg Close — Range —
Q1 2025
Shares 225,034 Value ($000) $1,028 Avg Close — Range —
Q4 2024
Shares 220,502 Value ($000) $1,244 Avg Close — Range —
Q3 2024
Shares 215,240 Value ($000) $1,042 Avg Close — Range —
Q2 2024
Shares 274,873 Value ($000) $1,341 Avg Close — Range —
Q1 2024
Shares 224,951 Value ($000) $2,987 Avg Close — Range —
Q4 2023
Shares 200,175 Value ($000) $2,790 Avg Close — Range —
Q3 2023
Shares 187,192 Value ($000) $2,482 Avg Close — Range —
Q2 2023
Shares 186,785 Value ($000) $3,502 Avg Close — Range —
Q1 2023
Shares 171,149 Value ($000) $2,468 Avg Close — Range —
Q4 2022
Shares 174,392 Value ($000) $3,374 Avg Close — Range —
Q3 2022
Shares 169,878 Value ($000) $5,835 Avg Close — Range —
Q2 2022
Shares 103,556 Value ($000) $1,583 Avg Close — Range —
Q1 2022
Shares 115,787 Value ($000) $2,642 Avg Close — Range —
Q4 2021
Shares 79,135 Value ($000) $2,918 Avg Close — Range —
Q3 2021
Shares 56,258 Value ($000) $2,644 Avg Close — Range —